Decreased Permeability Surface Area for Glucose in Obese Women with Postprandial Hyperglycemia: No Effect of Phosphodiesterase-5 (PDE-5) Inhibition

 

 Buy Article Permissions and Reprints

Abstract

Insulin-mediated microvascular recruitment is recognized as a potential mechanism contributing to insulin resistance. In this study, we compared a marker of microvascular function, the permeability surface area for glucose (PS_glu), and forearm glucose uptake after an OGTT in obese women with impaired glucose metabolism and healthy lean nondiabetic women, with the aim to characterize whether decreased permeability surface area for glucose or decreased glucose uptake may contribute to postprandial hyperglycemia in the obese group. In addition, we evaluated whether the phosphodiesterase-5 (PDE-5) inhibitor tadalafil, in a randomized double blind placebo controlled design, might attenuate postprandial glucose levels in obese women. For these purposes, intramuscular microdialysis, blood sampling from arterial and venous blood of the forearm, and measurements of forearm blood flow were performed. The results showed an impaired permeability surface area for glucose (IAUC PS_glu 31±13 vs. 124±31; p<0.05) in obese when compared with lean participants, but no differences in forearm glucose uptake appeared between the groups. Furthermore, a single dose of tadalafil 10 mg showed no improvement of the permeability surface area for glucose, glucose uptake, or circulating glucose levels in obese participants. In conclusion, the postprandial PS_glu response was impaired in obese women showing postprandial hyperglycemia, indicating a compromised microcirculation. However, we were unable to demonstrate any acute effect on either vascular function or glucose uptake of the phosphodiesterase-5 (PDE-5) inhibitor tadalafil.

• References

• 1 Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009; 58: 773-795
  CrossrefPubMedGoogle Scholar
• 2 White MF, Kahn CR. The insulin signaling system. J Biol Chem 1994; 269: 1-4
  PubMedGoogle Scholar
• 3 Yang YJ, Hope ID, Ader M, Bergman RN. Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 1989; 84: 1620-1628
  CrossrefPubMedGoogle Scholar
• 4 Chiu JD, Richey JM, Harrison LN, Zuniga E, Kolka CM, Kirkman E, Ellmerer M, Bergman RN. Direct administration of insulin into skeletal muscle reveals that the transport of insulin across the capillary endothelium limits the time course of insulin to activate glucose disposal. Diabetes 2008; 57: 828-835
  CrossrefPubMedGoogle Scholar
• 5 Sjostrand M, Gudbjornsdottir S, Holmang A, Lonn L, Strindberg L, Lonnroth P. Delayed transcapillary transport of insulin to muscle interstitial fluid in obese subjects. Diabetes 2002; 51: 2742-2748
  CrossrefPubMedGoogle Scholar
• 6 Sandqvist M, Strindberg L, Schmelz M, Lonnroth P, Jansson PA. Impaired delivery of insulin to adipose tissue and skeletal muscle in obese women with postprandial hyperglycemia. J Clin Endocrinol Metab 2011; 96: E1320-E1324
  CrossrefPubMedGoogle Scholar
• 7 Clerk LH, Vincent MA, Jahn LA, Liu Z, Lindner JR, Barrett EJ. Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes 2006; 55: 1436-1442
  CrossrefPubMedGoogle Scholar
• 8 Barrett EJ, Eggleston EM, Inyard AC, Wang H, Li G, Chai W, Liu Z. The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia 2009; 52: 752-764
  CrossrefPubMedGoogle Scholar
• 9 Kubota T, Kubota N, Kumagai H, Yamaguchi S, Kozono H, Takahashi T, Inoue M, Itoh S, Takamoto I, Sasako T, Kumagai K, Kawai T, Hashimoto S, Kobayashi T, Sato M, Tokuyama K, Nishimura S, Tsunoda M, Ide T, Murakami K, Yamazaki T, Ezaki O, Kawamura K, Masuda H, Moroi M, Sugi K, Oike Y, Shimokawa H, Yanagihara N, Tsutsui M, Terauchi Y, Tobe K, Nagai R, Kamata K, Inoue K, Kodama T, Ueki K, Kadowaki T. Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab 2011; 13: 294-307
  CrossrefPubMedGoogle Scholar
• 10 Keske MA, Clerk LH, Price WJ, Jahn LA, Barrett EJ. Obesity blunts microvascular recruitment in human forearm muscle after a mixed meal. Diabetes Care 2009; 32: 1672-1677
  CrossrefPubMedGoogle Scholar
• 11 Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846
  CrossrefPubMedGoogle Scholar
• 12 Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94: 1172-1179
  CrossrefPubMedGoogle Scholar
• 13 Vincent MA, Clerk LH, Lindner JR, Klibanov AL, Clark MG, Rattigan S, Barrett EJ. Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes 2004; 53: 1418-1423
  CrossrefPubMedGoogle Scholar
• 14 Murdolo G, Sjostrand M, Strindberg L, Gudbjornsdottir S, Lind L, Lonnroth P, Jansson PA. Effects of Intrabrachial metacholine infusion on muscle capillary recruitment and forearm glucose uptake during physiological hyperinsulinemia in obese, insulin-resistant individuals. J Clin Endocrinol Metab 2008; 93: 2764-2773
  Google Scholar
• 15 Jansson PA, Murdolo G, Sjogren L, Nystrom B, Sjostrand M, Strindberg L, Lonnroth P. Tadalafil increases muscle capillary recruitment and forearm glucose uptake in women with type 2 diabetes. Diabetologia 2010; 53: 2205-2208
  CrossrefPubMedGoogle Scholar
• 16 Ayala JE, Bracy DP, Julien BM, Rottman JN, Fueger PT, Wasserman DH. Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Diabetes 2007; 56: 1025-1033
  CrossrefPubMedGoogle Scholar
• 17 Hill KD, Eckhauser AW, Marney A, Brown NJ. Phosphodiesterase 5 inhibition improves beta-cell function in metabolic syndrome. Diabetes Care 2009; 32: 857-859
  CrossrefPubMedGoogle Scholar
• 18 Gupta M, Kovar A, Meibohm B. The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction. J Clin Pharmacol 2005; 45: 987-1003
  CrossrefPubMedGoogle Scholar
• 19 Strindberg L, Lonnroth P. Validation of an endogenous reference technique for the calibration of microdialysis catheters. Scand J Clin Lab Invest 2000; 60: 205-211
  CrossrefPubMedGoogle Scholar
• 20 Whitney RJ. The measurement of volume changes in human limbs. J Physiol 1953; 121: 1-27
  PubMedGoogle Scholar
• 21 Wascher TC, Bammer R, Stollberger R, Bahadori B, Wallner S, Toplak H. Forearm composition contributes to differences in reactive hyperaemia between healthy men and women. Eur J Clin Invest 1998; 28: 243-248
  CrossrefPubMedGoogle Scholar
• 22 Paaske WP. Absence of restricted diffusion in adipose tissue capillaries. Acta Physiol Scand 1977; 100: 430-436
  CrossrefPubMedGoogle Scholar
• 23 Gudbjornsdottir S, Sjostrand M, Strindberg L, Lonnroth P. Decreased muscle capillary permeability surface area in type 2 diabetic subjects. J Clin Endocrinol Metab 2005; 90: 1078-1082
  CrossrefPubMedGoogle Scholar
• 24 Yki-Jarvinen H. Acute and chronic effects of hyperglycaemia on glucose metabolism. Diabetologia 1990; 33: 579-585
  CrossrefPubMedGoogle Scholar